期刊文献+

血管紧张素Ⅱ对脐血CD34^+细胞体外扩增的作用 被引量:7

Effect of Angiotensin Ⅱ on Cord Blood CD34^+ Cells Expansion In Vitro
下载PDF
导出
摘要 血管紧张素Ⅱ (AngⅡ )是肾素 血管紧张素系统的一种主要生物活性物质。为了研究它在造血系统中的影响 ,本实验通过体外细胞培养的方法 ,探讨AngⅡ与不同的细胞因子联合刺激脐血CD34+ 细胞生长和分化的作用。研究结果发现 ,悬浮培养体系中的AngⅡ可同时刺激BFU E和CFU GM的扩增 ,BFU E和CFU GM的数量在一定范围内随AngⅡ浓度 (0 0 1- 0 1μmol/L)的升高而增多 ;在半固体培养基中的AngⅡ则仅刺激CFU GM的形成 ,却不影响BFU E ;悬浮培养体系中AngⅡ与细胞因子SCF +G CSF +GM CSF +IL 3联合可使CFU GM的扩增倍数由 2 3± 0 8升高到 7 8± 1 9倍 ,与SCF +EPO +TPO +IL 3联合 ,BFU E的扩增倍数由 3 1± 1 8提高到 9 2± 2 3倍。结论 :AngⅡ与其他细胞因子联合可刺激脐血造血干 /祖细胞体外扩增。 Angiotensin Ⅱ (Ang Ⅱ) is one active substance of renin angiotensin system. In order to explore the effect of Ang Ⅱ combined with various cytokines on proliferation and differentiation of cord blood CD34 + cells, in vitro expreriments of cell cultures of Ang Ⅱ with or without cytokines were taken place. The results showed that Ang Ⅱ stimulated both BFU E and CFU GM expansion. The numbers of BFU E and CFU GM raised with increase of Ang Ⅱ concentrations ranged from 0 01-0 1 μmol/L. In semi solid culture assay, Ang Ⅱ stimulated CFU GM production but no effect on BFU E occured. The multiple number of CFU GM increased from 2.3±0.8 to 7.8±1.9 times when Ang Ⅱ was added into SCF+G CSF+GM CSF+IL 3 combination. Similarly, the multiple number of BFU E increased from 3 1±1.8 to 9.2±2.3 times when Ang Ⅱ was combined with SCF+EPO+TPO+IL 3. In conclusion, Ang Ⅱ stimulated cord blood hematopoietic stem/progenitor cell expansion in vitro the in presence of various cytokines.
出处 《中国实验血液学杂志》 CAS CSCD 2003年第3期227-229,共3页 Journal of Experimental Hematology
关键词 血管紧张素Ⅱ 脐血 造血干/祖细胞 体外扩增 angiotensin Ⅱ cord blood hematopoietic stem/progenitor cell expansion in vitro
  • 相关文献

参考文献4

  • 1Julian BA, Brantley RR Jr, Barker CV, a al. Losartan, an angiotensin II type 1 receptor antagonist, lowers heanatocrit in posttransplant erythrocytosis. J Am Soe Nephrol, 1998; 9:1104- 1108.
  • 2Ducloux D, Fournier V, Bresson-Vautrin C, et al. Long-ternffol-low-up of renal transplant recipients treated with losartan for posttransplant erythrosis. Transpl Int, 1998; 11:312- 315.
  • 3Cole J, Ertoy D, Lin H, et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-defi-cient mice. J Clin Invest, 2000; 106:1391 - 1398.
  • 4Mrug M, Stopka T, Julian BA, et al. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest,1997; 100:2310- 2314.

同被引文献56

  • 1宋海燕,刘素芳,赵东风.记忆合金聚髌器对髌骨骨折术后患者下肢功能康复的影响[J].中国临床康复,2005,9(2):44-44. 被引量:1
  • 2马宪敏,余帆,秦贞立.人脐血临床研究及应用进展[J].中国临床保健杂志,2005,8(3):283-285. 被引量:4
  • 3潘继红,何秀玲,邹文霞.提高脐带血采集质量的策略及意义[J].宁夏医学院学报,2005,27(3):246-248. 被引量:6
  • 4陈镭,苗宗宁,张东强,陆华,王玲,栾文忠,惠国桢.人脐血源性间充质干细胞的体外培养及生物学鉴定[J].江苏医药,2005,31(7):481-483. 被引量:16
  • 5Gossmann J, Burkhardt R, Harder S, et al. Angiotensin Ⅱ infusion increases plasma erythropoietin levels via an angiotensin Ⅱ type Ⅰ receptor-dependent pathway. Kidney Int,2001,60(1):83-86.
  • 6Natio M,Kawashima A, Akiba T, et al. Effects of an angiotensin Ⅱreceptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients. Am J Nephrol, 2003,23(5):287-293.
  • 7Albitar S, Genin R, Fen CM, et al. High dose enalapril impairs the response to erythropoietin treatment in hemodialysis,potients.Nephrol Dial Transplant, 1998,12:1206.
  • 8Glicklich D, Kapoian T, Mian H, et al. Effects of erythropoietin, angiotensin Ⅱ,and angiotensin-converting enzyme inhibitior on erythroid precursors in patients with posttransplant erythrocytosis.Clinical Transplantation, 1999,68(1):62-66.
  • 9Odabas AR, Cetinkaya R, Selcuk Y, et al. The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis. Panminerva Med,2003,45(1):59-62.
  • 10Marrero MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/Stat pathway by the angiotensin Ⅱ AT1 receptor. Nature,1995,375(1): 247.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部